Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Buy dildos and sex toys.
Popular Articles

NICE Upholds GlaxoSmithKline Appeal For Advanced Breast Cancer Treatment, Tyverb(R)(lapatinib)
The National Institute for Health and Clinical Excellence (NICE) announced that, following GlaxoSmithKline"s (GSK) appeal, it will reconsider the submission for Tyverb (lapatinib), a treatment for an aggressive form of advanced breast cancer (ErbB2-positive).1 GSK is pleased that NICE"s appeal panel agreed that the draft negative guidance should be reviewed, providing fresh hope for up to 2,000 women in the UK who could benefit from this effective treatment on the NHS.
buy viagra
Surgery, Oral Devices Associated With Improvement In Sleep Breathing Disorder
Treatment with surgery or an oral appliance that adjusts the jaw is associated with improvements in obstructive sleep apnea, a condition caused by blocked upper airways in which patients periodically stop breathing during sleep, according to two reports in the May issue of Archives of Otolaryngology-Head & Neck Surgery, one of the JAMA/Archives journals.
News of the day
Platypus Link To Ovarian Cancer
Researchers from the Royal Adelaide Hospital and University of Adelaide believe our oldest mammalian relative may help us to better understand ovarian cancer.
Nutrition

Cambridge Consultants To Showcase Inhaler Design And Development Process At RDD 2009, Europe

Cambridge Consultants will be showcasing its proprietary design and development process for Dry Power Inhalers (DPIs) at the Respiratory Drug Delivery (RDD) Europe 2009 conference in Lisbon later this month.÷  The company will demonstrate its ability to move inhaler design quickly through all stages of development from concept through manufacture to final product, getting it right first time, accelerating the creation of new inhalable drug delivery devices, and offering pharmaceutical companies a quick route to market, saving up to six months in development. "Our RDD presence is all about the importance of speed to market, and this demonstration is designed to highlight the range of development capabilities we can deploy to achieve it for our clients," commented David Blakey, Head of Drug Delivery at Cambridge Consultants.÷  "It is crucial to ensure process quality in stages such as concept creation, complex mathematical modelling and detailed design.÷  These are areas where Cambridge Consultants adds significant value, based on our skill and experience in running turn key developments, from concept to clinical trial and through transfer to manufacture." Cambridge Consultants will be using Gen-X, a proprietary DPI, to demonstrate the key stages in the design cycle.÷  The display tracks the stages of the process up to the test bed stage, where the efficacy of the de-aggregation engine has been tested.÷  Cambridge Consultants is currently selecting development partners to take this concept to market. David Blakey adds: "Supported by our proprietary design and development process, our partners can cut up to six months off the development cycle for DPIs, giving them a significant head start and reducing development risk." The demonstration of Cambridge Consultants" product development process will be available on Cambridge Consultants" stand at the Respiratory Drug Delivery Europe 2009 conference in Lisbon, Portugal, from 19-22 May. Cambridge Consultants


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009